A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients
Clinical trial NCT07303660 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07303660
- Sponsor
- Lomond Therapeutics Holdings, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-10
- Primary completion
- 2026-09-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.